Dr. Cooper’s lifesaving work in giant cell myocarditis patients featured by Mayo Clinic

Dr. Leslie Cooper, Myocarditis Foundation Co-Founder and Board Member, began researching giant cell myocarditis dr-cooper-lg.jpg(GCM) in 1993 when there was no treatment other than heart transplant and not many patients lived long enough to receive one. Dr. Cooper developed a treatment regiment using immunosuppressive drugs which increased one year survival to 91%.

One of the people that Dr. Cooper’s research and treatment saved was Hal Stahl when he developed GCM at 47. 19 years later Hal is living a full life due to early diagnosis and Dr. Cooper’s lifesaving cure.

Read Mayo Clinic’s story about Hal Stahl and Dr. Cooper.